Measuring hCG in Bladder Cancer Patients
Author Information
Author(s): J Moral, N Gascon, JMa Tabernero, J Rodriguez-Espinosal, F Gonzalez-Sastre
Primary Institution: Hospital de Sant Pau
Hypothesis
Different hCG assays will have varying diagnostic sensitivities in bladder carcinoma patients with ectopic hCG secretion.
Conclusion
The study found that t-hCG and free β-hCG assays are the most suitable for managing bladder carcinoma patients.
Supporting Evidence
- The diagnostic sensitivity of t-hCG assays ranged from 63.6% to 75.7%.
- Free β-hCG assay had a diagnostic sensitivity of 72.7%.
- i-hCG assay had a sensitivity of only 6%.
- Median increases of hCG during treatment ranged from 4.9 to 6.9 for t-hCG and free β-hCG assays.
Takeaway
Doctors tested different ways to measure a hormone called hCG in bladder cancer patients, and found that some tests work better than others.
Methodology
The study evaluated various hCG assays in bladder carcinoma patients at diagnosis and during treatment.
Limitations
The study focused on patients with raised hCG values, which may not represent the general population.
Participant Demographics
33 bladder carcinoma patients, 30 men and 3 women, aged 42-75 years.
Want to read the original?
Access the complete publication on the publisher's website